Causes of Ehlers-Danlos Syndrome, Hypermobility
User reported causes of Ehlers-Danlos Syndrome, Hypermobility based on their intuition.
| Cause | Agree |
|---|---|
| Genetics | 97% |
| Stress to Joints (I.e. Heavy Lifting) | 80% |
| Standing for Extended Periods of Time | 75% |
| Frail Cartilage | 50% |
| Became Deconditioned (Lots of Rest Due to Another Problem) | 46% |
Treatments
User-reported effectiveness in treating Ehlers-Danlos Syndrome, Hypermobility
| Treatment | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Pilates | 4% | 40% | 12% | 36% | 8% | 25 |
| Massage | 16% | 48% | 5% | 16% | 15% | 62 |
| Physical Therapy | 17% | 26% | 11% | 32% | 14% | 72 |
| Ibuprofen | 8% | 46% | 0% | 42% | 3% | 59 |
| TENS | 0% | 50% | 15% | 35% | 0% | 40 |
| Acupuncture | 5% | 26% | 3% | 55% | 11% | 38 |
| Yoga | 8% | 25% | 10% | 33% | 25% | 40 |
| Ice | 4% | 47% | 11% | 24% | 13% | 70 |
| Heat | 11% | 64% | 0% | 21% | 4% | 80 |
| Naproxen | 5% | 38% | 8% | 46% | 3% | 39 |
| Glucosamine | 0% | 14% | 11% | 69% | 6% | 35 |
| Tramadol | 5% | 35% | 10% | 25% | 25% | 20 |
| Magnesium | 10% | 20% | 0% | 68% | 2% | 41 |
| Vitamin D | 2% | 34% | 2% | 61% | 2% | 56 |
| Vitamin C | 9% | 17% | 2% | 72% | 0% | 46 |
| Vicodin (Hydrocodone) | 22% | 44% | 11% | 17% | 6% | 18 |
| MSM | 7% | 14% | 0% | 79% | 0% | 14 |
| Fentanyl Patch | 33% | 0% | 0% | 67% | 0% | 3 |
| Calcium | 2% | 10% | 4% | 84% | 0% | 50 |
| Midodrine | 60% | 20% | 0% | 20% | 0% | 5 |
| Savella | 25% | 0% | 25% | 25% | 25% | 4 |
| Voltaren Gel | 8% | 31% | 15% | 46% | 0% | 13 |
| Excedrin Migraine | 4% | 54% | 4% | 38% | 0% | 26 |
| Florinef | 0% | 50% | 50% | 0% | 0% | 2 |
| Chiropractic Adjustment | 8% | 30% | 18% | 30% | 15% | 40 |
| ACDF (Anterior Cervical Discectomy & Fusion) | 75% | 25% | 0% | 0% | 0% | 4 |
| Lumbar Laminectomy/decompression | 50% | 33% | 17% | 0% | 0% | 6 |
| Mobic/Movalis/Melox/Recoxa (Meloxicam) | 24% | 35% | 6% | 35% | 0% | 17 |
| Spine Rehabilitation/ Pain Management | 21% | 36% | 7% | 32% | 4% | 28 |
| Posterior Lumbar Interbody Fusion (PLIF) | 25% | 50% | 0% | 25% | 0% | 4 |
| Radiofrequency Ablaition | 100% | 0% | 0% | 0% | 0% | 1 |
| Hyaluronic Acid (Hyaluronan) | 0% | 50% | 0% | 50% | 0% | 6 |
| Oramorph | 0% | 100% | 0% | 0% | 0% | 1 |
| Muscle Relaxors | 10% | 30% | 20% | 40% | 0% | 10 |
| Neurontin/Gabapentin | 33% | 0% | 17% | 17% | 33% | 6 |
| Fascet Injections | 33% | 0% | 33% | 0% | 33% | 3 |
| SI Injections | 33% | 0% | 67% | 0% | 0% | 3 |
| Chondroitin/Chondroitin Sulfate | 0% | 8% | 8% | 76% | 8% | 25 |
Predictors
Below is the change in Ehlers-Danlos Syndrome, Hypermobility seen after the predictor is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Predictors Label
Ehlers-Danlos Syndrome, Hypermobility Info
| Property | Value |
|---|---|
| Variable Name | Ehlers-Danlos Syndrome, Hypermobility |
| Aggregation Method | MEAN |
| Analysis Performed At | 2020-03-02 |
| Duration of Action | 24 hours |
| Maximum Allowed Value | 5 out of 5 |
| Minimum Allowed Value | 1 out of 5 |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 0 seconds |
| Unit | 1 to 5 Rating |
| User Variables | 0 |
| Variable Category | Symptoms |
| Variable ID | 86820 |